Insider sale
NEWAMSTERDAM PHARMA CO N.V.
$21.80M
1.44M shares
What this filing means
NAP POOLCO B.V. plans to sell 1.44M shares of NEWAMSTERDAM PHARMA CO N.V. valued at approximately $21.80M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 4/11/2025ACC: 0001973141-25-000177
1.44M
Shares to sell
$21.80M
Approx. market value
1.43M
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Initial Public Offering
Cash
11/15/2022
1.43MTotal acquired1.43M
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
11/15/2022 | Initial Public Offering Cash | 1.43M | — |
| Total | 1.43M | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
5.29K
Market value
$132.8K
1/13/2025
Planned — Approximate Date
NasdaqPlanned
Units to sell
1.43M
Market value
$21.67M
4/11/2025
Total
Units
1.44M
Value
$21.80M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
1/13/2025 | 5.29K | $132.8K | — | Completed |
| Planned — Approximate Date | ||||
4/11/2025 | 1.43M | $21.67M | Nasdaq | Planned |
| Total | 1.44M | $21.80M | ||